Objective To explore the correlation between nutritional status and frailty in elderly patients with cardiovascular disease (CVD), and to provide suggestions for the prevention of frailty occurrence in elderly patients with CVD. Methods A retrospective study was conducted on 357 elderly CVD patients who were admitted to the Third Affiliated Hospital of Chengdu Medical College from May 2024 to July 2024. These patients were divided into a frailty group and a non-frailty group based on the presence or absence of frailty. Data on the patients' nutritional status indicators [body mass index (BMI), weight loss, calf circumference, albumin, and grip strength], general demographic and clinical data, laboratory and physiological indicators, and functional and activity indicators were collected. The influencing factors of frailty and the correlation between nutritional status indicators and frailty were analyzed. Results Among the 357 patients, 69 cases (19.33%) were detected with frailty, while 288 (80.67%) were without frailty. Multivariate logistic regression analysis revealed that age (OR=1.120, 95% CI: 1.023–1.225) and weight loss (OR=2.776, 95% CI: 1.145–6.732) were risk factors influencing the occurrence of frailty in elderly CVD patients (P<0.05), while grip strength (OR=0.902, 95% CI: 0.831–0.980), albumin level (OR=0.892, 95% CI: 0.806–0.988), and calf circumference (OR=0.900, 95% CI: 0.829–0.978) were protective factors of frailty occurrence in elderly CVD patients (P<0.05). Conclusion The incidence rate of frailty is relatively high in elderly patients with CVD. Age and weight loss are independent risk factors for frailty, while high grip strength level, high albumin level, and large calf circumference are independent protective factors of frailty.

Background and Objectives: With the growing incidence of acute myocardial infarction (MI), angiogenesis is vital for cardiac function post-MI. The role of bone marrow mesenchymal stem cells (BMSCs) in angiogenesis has been previously confirmed. Irisin is considered a potential vector for angiogenesis. The objective of the present study was to investigate the potential role of irisin in the angiogenesis of BMSCs. Methods: and Results: In vivo, irisin-treated BMSCs (BMSCs＋irisin) were transplanted into an MI mouse model. On day 28 post-MI, blood vessel markers were detected, and cardiac function and infarct areas of mice were evaluated. In vitro, paracrine effects were assessed by examining tube formation in human umbilical vein endothelial cells (HUVECs) co-cultured with the BMSCs＋irisin supernatant. The scratch wound-healing assay was performed to evaluate HUVEC migration. Western blotting was performed to determine PI3k/Akt pathway activation in the BMSCs＋irisin group. Transplantation of BMSCs＋irisin promoted greater angiogenesis, resulting in better cardiac function in the MI mouse model than in controls. In the BMSC＋irisin group, HUVECs demonstrated enhanced tube formation and migration. Activation of the PI3k/Akt pathway was found to be involved in mediating the role of irisin in the angiogenesis of BMSCs. Conclusions In cardiovascular diseases such as MI, irisin administration can enhance angiogenesis of BMSCs and pro-mote cardiac function via the PI3k/Akt pathway, optimizing the therapeutic effect based on BMSCs transplantation.